Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
**Chicory inulin-type fructan** is a natural, plant-derived dietary fiber primarily extracted from the root of *Cichorium intybus* (chicory). It is made up of linear fructose polymers (fructans) linked mainly by β-(2→1) bonds, which are resistant to human digestive enzymes, resulting in prebiotic activity within the gut. Mechanistically, chicory inulin-type fructan acts as a soluble fiber that increases stool bulk, modulates gut microbiota—stimulating beneficial species like *Bifidobacterium* and *Lactobacillus*—and reduces constipation symptoms[1][2][3]. Human studies further associate its intake with improvements in bowel movement frequency and consistency, potential antihyperglycemic effects (notably lowering HbA1c), modulation of lipid metabolism (adiponectin increase), and modest reductions in body weight, BMI, fat mass, and waist circumference[2][3]. Clinical use is as a **dietary supplement** for digestive health, weight management, and metabolic support.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on chicory inulin-type fructan.